An Update on Breast Cancer Biomarkers

Abstract

Breast cancer is the most common cancer that affects millions of people worldwide. Delayed diagnosis of these cancers has increased the morbidity and mortality. However, the vast research on cancer biomarkers during recent years provide a powerful and dynamic approach to understand the wide spectrum of cancers with applications in prognosis, diagnosis, screening, randomized clinical trials, and observational and analytic epidemiology. Cancer biomarkers have tremendously increased the efficacy of treatment and efficacy of detection. We have comprehensively summarized various biomarkers of breast cancer and highlighted recent research.

Efficacy of Mastocheck for Screening of Early Breast Cancer: Comparison with Screening Mammography

“…Yumi Kim, et al Mastocheck for Screening of Breast Cancer mended blood test for the diagnosis of breast cancer, its value as a diagnostic or prognostic factor for various tumor markers based on blood tests is being studied [8][9][10][11]. We have developed a blood marker for breast cancer diagnosis using proteomic techniques through numerous experiments over 10 years using tissue, blood, and cell samples.…”